Advertisement

Loading...

CLS Holdings USA, Inc.

CLSH.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$-0.01(-22.22%)
Canadian Market opens in 16h 37m

CLS Holdings USA, Inc. Fundamental Analysis

CLS Holdings USA, Inc. (CLSH.CN) shows weak financial fundamentals with a PE ratio of -0.11, profit margin of -4.57%, and ROE of 3.25%. The company generates $1.1B in annual revenue with weak year-over-year growth of -13.71%.

Key Strengths

Cash Position382.75%
PEG Ratio0.00

Areas of Concern

ROE3.25%
Operating Margin-8.94%
Current Ratio0.17
We analyze CLSH.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 11.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
11.2/100

We analyze CLSH.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

CLSH.CN struggles to generate sufficient returns from assets.

ROA > 10%
-5.26%

Valuation Score

Excellent

CLSH.CN trades at attractive valuation levels.

PE < 25
-0.11
PEG Ratio < 2
0.00

Growth Score

Moderate

CLSH.CN shows steady but slowing expansion.

Revenue Growth > 5%
-13.71%
EPS Growth > 10%
80.26%

Financial Health Score

Moderate

CLSH.CN shows balanced financial health with some risks.

Debt/Equity < 1
-0.42
Current Ratio > 1
0.17

Profitability Score

Weak

CLSH.CN struggles to sustain strong margins.

ROE > 15%
3.25%
Net Margin ≥ 15%
-4.57%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CLSH.CN Expensive or Cheap?

P/E Ratio

CLSH.CN trades at -0.11 times earnings. This suggests potential undervaluation.

-0.11

PEG Ratio

When adjusting for growth, CLSH.CN's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values CLS Holdings USA, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 1.01 times EBITDA. This is generally considered low.

1.01

How Well Does CLSH.CN Make Money?

Net Profit Margin

For every $100 in sales, CLS Holdings USA, Inc. keeps $-4.57 as profit after all expenses.

-4.57%

Operating Margin

Core operations generate -8.94 in profit for every $100 in revenue, before interest and taxes.

-8.94%

ROE

Management delivers $3.25 in profit for every $100 of shareholder equity.

3.25%

ROA

CLS Holdings USA, Inc. generates $-5.26 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.26%

Following the Money - Real Cash Generation

Operating Cash Flow

CLS Holdings USA, Inc. generates limited operating cash flow of $9.68M, signaling weaker underlying cash strength.

$9.68M

Free Cash Flow

CLS Holdings USA, Inc. generates weak or negative free cash flow of $7.02M, restricting financial flexibility.

$7.02M

FCF Per Share

Each share generates $0.03 in free cash annually.

$0.03

FCF Yield

CLSH.CN converts 0.86% of its market value into free cash.

0.86%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.11

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.73

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.42

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.17

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

0.07

vs 25 benchmark

How CLSH.CN Stacks Against Its Sector Peers

MetricCLSH.CN ValueSector AveragePerformance
P/E Ratio-0.1127.91 Better (Cheaper)
ROE3.25%687.00% Weak
Net Margin-4.57%-45285.00% (disorted) Weak
Debt/Equity-0.420.33 Strong (Low Leverage)
Current Ratio0.172795.76 Weak Liquidity
ROA-5.26%-13557.00% (disorted) Weak

CLSH.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CLS Holdings USA, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-38.62%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

95.77%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

102.07%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ